ESR1 and breast carcinoma: Recently, it has been demonstrated that certain aqueous extracts containing LBPs inhibit the in vitro growth of the ER+ human breast cancer MCF-7 cell line, suggesting the alteration of estradiol cellular metabolism as a mechanism [137].